Report cover image

Intramuscular Vaccine Adjuvants Market

Publisher Coherent Market Insights
Published Aug 20, 2025
Length 171 Pages
SKU # CMI20399661

Description

Vaccines are considered as one of the most effective methods for the prevention and control of infectious diseases. This is primarily due to their ability to target specific pathogens and stimulate the immune system. Moreover, these products are also inexpensive and can be used to treat multiple diseases simultaneously.

Market Dynamics

The global intramuscular vaccine adjuvants market is expected to experience substantial growth during the forecast period due to several factors. These include an increased demand for safe and effective vaccines, the ongoing pace of innovation in this field, and financial support from various private and public sector investors. A growing geriatric population coupled with increasing prevalence of chronic diseases are other major drivers fuelling growth of the global vaccine adjuvants market. Moreover, the presence of large numbers of hospitals and other healthcare facilities is also expected to propel market growth during the forecast period. In addition, the emergence of novel therapeutics is further expected to boost market growth.

On the other hand, side-effects and toxicity of adjuvants is expected to hinder the market growth.

Key features of the study
  • This report provides in-depth analysis of the global intramuscular vaccine adjuvants market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global intramuscular vaccine adjuvants market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Novavax, Inc., Adjuvance Technologies, Inc., Invivogen, Vaxine Pty Ltd., SEPPIC, SPI Pharma, Inc., Agenus Inc., Avanti Polar Lipids, Inc., CSL Limited, and OZ Biosciences.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global intramuscular vaccine adjuvants market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global intramuscular vaccine adjuvants market.
Market Segmentation
  • Global Intramuscular Vaccine Adjuvants Market, By Type of Adjuvants
  • Oil-based Adjuvants
  • Liposome-based Adjuvants
  • Polymer-based Adjuvants
  • Mineral-based Adjuvants
  • Others
  • Global Intramuscular Vaccine Adjuvants Market, By End Users
  • Pediatrics
  • Adults
  • Geriatrics
  • Global Intramuscular Vaccine Adjuvants Market, By Applications
  • Infectious diseases
  • Cancer
  • Others
  • Global Intramuscular Vaccine Adjuvants Market, By Distribution Channels
  • Hospitals
  • Clinics
  • Research Centers
  • Global Intramuscular Vaccine Adjuvants Market, By Region
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
  • Global Intramuscular Vaccine Adjuvants Market Companies
  • Novavax, Inc.
  • Adjuvance Technologies, Inc.
  • Invivogen
  • Vaxine Pty Ltd.
  • SEPPIC
  • SPI Pharma, Inc.
  • Agenus Inc.
  • Avanti Polar Lipids, Inc.
  • CSL Limited
  • OZ Biosciences

Table of Contents

171 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Intramuscular Vaccine Adjuvants, By Type of Adjuvants
Market Intramuscular Vaccine Adjuvants, By End users
Market Intramuscular Vaccine Adjuvants, By Applications
Market Intramuscular Vaccine Adjuvants, By Distribution Channels
Market Intramuscular Vaccine Adjuvants, By Region
Coherent Opportunity Map (COM)
3. Global Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Growing geriatric population coupled with increasing prevalence of chronic diseases
Increased government vaccination recommendations
Restraints
Side-effects and toxicity of adjuvants
Opportunities
Increased research and development activities in this field
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Global Intramuscular Vaccine Adjuvants Market, By Type of Adjuvants, 2020-2032, (USD Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2025 – 2032
Segment Trends
Oil-based Adjuvants
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Liposome-based Adjuvants
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Liposome-based Adjuvants
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Mineral-based Adjuvants
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
5. Global Intramuscular Vaccine Adjuvants Market, By End Users, 2020-2032, (USD Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2025 – 2032
Segment Trends
Pediatrics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Adults
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Geriatrics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
6. Global Intramuscular Vaccine Adjuvants Market, By Applications, 2020-2032, (USD Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2025 – 2032
Segment Trends
Infectious diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
7. Global Intramuscular Vaccine Adjuvants Market, By Distribution Channels, 2020-2032, (USD Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2025 – 2032
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Research Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
8. Global Intramuscular Vaccine Adjuvants Market, By Region, 2020-2032, (USD Mn)
Introduction
Market Share Analysis, By Country, 2025 and 2032 (%)
Y-o-Y Growth Analysis, For Country 2025 –2032
Country Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Mn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type of Adjuvants, 2020-2032, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End Users, 2020-2032, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Applications, 2020-2032, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channels, 2020-2032, (USD Mn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type of Adjuvants, 2020-2032, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End Users, 2020-2032, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Applications, 2020-2032, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channels, 2020-2032, (USD Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type of Adjuvants, 2020-2032, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End Users, 2020-2032, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Applications, 2020-2032, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channels, 2020-2032, (USD Mn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East & Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type of Adjuvants, 2020-2032, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End Users, 2020-2032, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Applications, 2020-2032, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channels, 2020-2032, (USD Mn)
GCC Countries
Israel
Rest of Middle East
South Africa
North Africa
Central Africa
9. Competitive Landscape
Novavax, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Adjuvance Technologies, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Invivogen
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Vaxine Pty Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
SEPPIC
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
SPI Pharma, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Agenus Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Avanti Polar Lipids, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
CSL Limited
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
OZ Biosciences
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Analyst Views
10. Section
Research Methodology
About us

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us